Viewing Study NCT00369395


Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2026-01-29 @ 6:11 AM
Study NCT ID: NCT00369395
Status: TERMINATED
Last Update Posted: 2012-04-27
First Post: 2006-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Volociximab in Metastatic Melanoma
Sponsor: Abbott
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage IV Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None melanoma View
None antibody View
None angiogenesis View
None volociximab View